Literature DB >> 2999404

Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor.

B V Cheney, J Szmuszkovicz, R A Lahti, D A Zichi.   

Abstract

In this paper, we describe the synthesis of a series of trans-N-[2-(methylamino)cyclohexyl]benzamides possessing morphine-like pharmacological properties. The affinity of the compounds for the agonist and antagonist states of the mu opioid receptor has been established by means of an in vitro binding assay. We have investigated the geometry and electronic structure of the molecules using molecular mechanics and an ab initio SCF-MO procedure with FSGO basis sets. Comparison to naloxone reveals properties of possible importance in receptor association. We have considered both the S,S and R,R isomers in the binding model. Statistical analyses imply that three factors play a significant role in binding: (1) membrane-water partitioning, (2) the capacity of the aromatic ring and amine N-substituent to act as electron acceptors, (3) the conformational energy required to attain the binding configuration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999404     DOI: 10.1021/jm00150a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.

Authors:  C G Parsons; D C West; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.

Authors:  Michael H Baumann; Susruta Majumdar; Valerie Le Rouzic; Amanda Hunkele; Rajendra Uprety; Xi Ping Huang; Jin Xu; Bryan L Roth; Ying-Xian Pan; Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

3.  Another fatal case related to the recreational abuse of U-47700.

Authors:  Nadine Strehmel; Denise Dümpelmann; Elke Vejmelka; Veronika Strehmel; Sonja Roscher; Stefan Scholtis; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2018-09-18       Impact factor: 2.007

4.  Comparing fatal cases involving U-47700.

Authors:  Xiulu Ruan; Srinivas Chiravuri; Alan D Kaye
Journal:  Forensic Sci Med Pathol       Date:  2016-07-16       Impact factor: 2.007

5.  Fatalities associated with NPS stimulants in the Greater Cologne area.

Authors:  Sabrina Lehmann; Tobias Kieliba; Mario Thevis; Markus A Rothschild; Katja Mercer-Chalmers-Bender
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

6.  Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.

Authors:  Camille Richeval; Jean-Michel Gaulier; Ludovic Romeuf; Delphine Allorge; Yvan Gaillard
Journal:  Int J Legal Med       Date:  2018-11-15       Impact factor: 2.686

Review 7.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

8.  Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats.

Authors:  Michael T Truver; Christina R Smith; Nancy Garibay; Theresa A Kopajtic; Madeleine J Swortwood; Michael H Baumann
Journal:  Neuropharmacology       Date:  2020-06-10       Impact factor: 5.250

Review 9.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

10.  Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures.

Authors:  Elan Barenholtz; Alex J Krotulski; Paul Morris; Nicole D Fitzgerald; Austin Le; Donna M Papsun; Barry K Logan; William E Hahn; Bruce A Goldberger; Linda B Cottler; Joseph J Palamar
Journal:  Int J Drug Policy       Date:  2021-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.